HTH is a venture capital fund based in Milan, focusing on Series C investments ranging from $250k to $5M. They target sectors such as biotech, manufacturing, and health tech, and have invested in companies like Univercells. HTH supports businesses with cutting-edge technologies in life sciences, working with both early and mid-stage companies, and invests internationally. The fund is backed by an entrepreneur in the healthcare sector.
